🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Perianal Fistula Due to Crohn's Disease

Risankizumab for Refractory Perianal Fistulizing Crohn's Disease NCT07872449Phase 44 sites📍 Nishinomiya📍 Shinjuku-Ku📍 Yokohama Yuki Horio · Tests: Risankizumab TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease NCT06051253Phase 41 site📍 Seoul Asan Medical Center · Tests: TDM-based infliximab intravenous therapy, Standard infliximab intravenous therapy DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease NCT06918808Phase 25 sites📍 Aurora📍 St Louis📍 New York Direct Biologics, LLC · Tests: DB-3Q, Placebo Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease NCT05039411Phase 11 site📍 Kuala Lumpur CryoCord Sdn Bhd · Tests: PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy